- Home
- UNCY vs ASPC Comparison
UNCY vs ASPC Comparison
Compare UNCY & ASPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- ASPC
- Stock Information
- Founded
- UNCY 2016
- ASPC 2024
- Country
- UNCY United States
- ASPC Hong Kong
- Employees
- UNCY N/A
- ASPC N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- ASPC
- Sector
- UNCY Health Care
- ASPC
- Exchange
- UNCY Nasdaq
- ASPC Nasdaq
- Market Cap
- UNCY 91.0M
- ASPC 82.6M
- IPO Year
- UNCY 2021
- ASPC 2024
- Fundamental
- Price
- UNCY $4.87
- ASPC $10.26
- Analyst Decision
- UNCY Strong Buy
- ASPC
- Analyst Count
- UNCY 4
- ASPC 0
- Target Price
- UNCY $63.75
- ASPC N/A
- AVG Volume (30 Days)
- UNCY 934.5K
- ASPC 3.0K
- Earning Date
- UNCY 08-13-2025
- ASPC 01-01-0001
- Dividend Yield
- UNCY N/A
- ASPC N/A
- EPS Growth
- UNCY N/A
- ASPC N/A
- EPS
- UNCY N/A
- ASPC 0.05
- Revenue
- UNCY N/A
- ASPC N/A
- Revenue This Year
- UNCY N/A
- ASPC N/A
- Revenue Next Year
- UNCY $1,458.53
- ASPC N/A
- P/E Ratio
- UNCY N/A
- ASPC $220.96
- Revenue Growth
- UNCY N/A
- ASPC N/A
- 52 Week Low
- UNCY $2.02
- ASPC $9.95
- 52 Week High
- UNCY $11.00
- ASPC $10.51
- Technical
- Relative Strength Index (RSI)
- UNCY 45.55
- ASPC N/A
- Support Level
- UNCY $4.38
- ASPC N/A
- Resistance Level
- UNCY $4.96
- ASPC N/A
- Average True Range (ATR)
- UNCY 0.31
- ASPC 0.00
- MACD
- UNCY 0.05
- ASPC 0.00
- Stochastic Oscillator
- UNCY 41.88
- ASPC 0.00
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About ASPC A SPAC III Acquisition Corp. Class A Ordinary Shares
A SPAC III Acquisition Corp is a blank check company.